Call for Papers  

Article Details

Treatment of Allergic Asthma by Targeting Transcription Factors Using Nucleic-Acid Based Technologies

[ Vol. 12 , Issue. 25 ]


Serdar Sel, Wolfgang Henke, Alexander Dietrich, Udo Herz and Harald Renz   Pages 3293 - 3304 ( 12 )


There is considerable evidence that T-helper 2 (Th2) cells play a central role in the pathogenesis of allergic diseases such as bronchial asthma, hay fever or food allergy. The differentiation of naïve T cells into Th2 cells producing a specific pattern of cytokines is tightly controlled and regulated by transcription factors. Thus down-regulation of mRNAlevels of a single transcription factor leads to a “knock-down” of several mediators simultaneously, representing an advantage compared to earlier approaches involving down-regulation of one intercellular inflammatory mediator, which is unlikely to influence all pathophysiological aspects of the disease. We review the impact of specific and master transcription factors involved in Th2 cell commitment and evaluate approaches for the down-regulation of these proteins by degradation of their mRNA using nucleic-acid based technologies including antisense oligonucleotides, ribozymes, DNAzymes, decoys oligonucleotides and RNA interference.


Nucleic-acid based technology,antisense,therapeutic tool,transcription factor,allergy,asthma


, , , , Department of Clinical Chemistry and Molecular Diagnostics, Hospital of the Philipps University Marburg, Baldingerstrasse, D-35033 Marburg, Germany.

Read Full-Text article